CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler



– Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant’s Potential Products – REHOVOT, Israel, Nov. 1, 2023 /PRNewswire/ — CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and…

Leave a Reply